Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries

Linde, L, Georgiadis, S, Ørnbjerg, L M, Rasmussen, S H, Michelsen, B, Askling, J, Di Giuseppe, D, Wallman, J K, Závada, J, Pavelka, K, Bernardes, M, Matos, C O, Glintborg, B, Loft, A G, Nordström, D, Kuusalo, L, Möller, B, Nissen, M J, Codreanu, C, Mogosan, C, Gudbjornsson, B, Love, T J, Akleylek, C, Iannone, F, Kvien, T K, Rotar, Z, Castrejon, I, Macfarlane, G J, Hetland, M L & Østergaard, M 2024, 'Comparing DAPSA, DAPSA28, and DAS28-CRP in Patients With Psoriatic Arthritis Initiating a First Tumor Necrosis Factor Inhibitor Across Nine European Countries', Arthritis Care and Research, vol. 76, no. 11, pp. 1558-1565. https://doi.org/10.1002/acr.25396